molecular function |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0005164 | | tumor necrosis factor receptor binding | | Interacting selectively and non-covalently with the tumor necrosis factor receptor. |
| GO:0032813 | | tumor necrosis factor receptor superfamily binding | | Interacting selectively and non-covalently with any member of the tumor necrosis factor receptor superfamily. |
biological process |
| GO:0035783 | | CD4-positive, alpha-beta T cell costimulation | | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment CD4-positive, alpha-beta T cell activation. |
| GO:0042098 | | T cell proliferation | | The expansion of a T cell population by cell division. Follows T cell activation. |
| GO:0035712 | | T-helper 2 cell activation | | The change in morphology and behavior of a T helper 2 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| GO:0002526 | | acute inflammatory response | | Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response. |
| GO:0001568 | | blood vessel development | | The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood. |
| GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| GO:0035714 | | cellular response to nitrogen dioxide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus. |
| GO:0071380 | | cellular response to prostaglandin E stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus. |
| GO:0071954 | | chemokine (C-C motif) ligand 11 production | | The appearance of chemokine (C-C motif) ligand 11 (CCL11, also known as eotaxin-1) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| GO:0008203 | | cholesterol metabolic process | | The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. |
| GO:0001816 | | cytokine production | | The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| GO:0002215 | | defense response to nematode | | A response to protect an organism from a directly detected or perceived external threat from a nematode or nematodes, which results in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack. |
| GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| GO:0035709 | | memory T cell activation | | The change in morphology and behavior of a memory T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| GO:0070233 | | negative regulation of T cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of T cell death by apoptotic process. |
| GO:0045626 | | negative regulation of T-helper 1 cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 1 cell differentiation. |
| GO:0070236 | | negative regulation of activation-induced cell death of T cells | | Any process that stops, prevents, or reduces the frequency, rate or extent of activation-induced cell death of T cells. |
| GO:0050710 | | negative regulation of cytokine secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell. |
| GO:2001237 | | negative regulation of extrinsic apoptotic signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| GO:0032689 | | negative regulation of interferon-gamma production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| GO:0032700 | | negative regulation of interleukin-17 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines. |
| GO:0045590 | | negative regulation of regulatory T cell differentiation | | Any process that stops, prevents, or reduces the rate of differentiation of regulatory T cells. |
| GO:0043433 | | negative regulation of sequence-specific DNA binding transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0050871 | | positive regulation of B cell activation | | Any process that activates or increases the frequency, rate or extent of B cell activation. |
| GO:1900281 | | positive regulation of CD4-positive, alpha-beta T cell costimulation | | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation. |
| GO:0043372 | | positive regulation of CD4-positive, alpha-beta T cell differentiation | | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell differentiation. |
| GO:2000525 | | positive regulation of T cell costimulation | | Any process that activates or increases the frequency, rate or extent of T cell costimulation. |
| GO:0002726 | | positive regulation of T cell cytokine production | | Any process that activates or increases the frequency, rate, or extent of T cell cytokine production. |
| GO:2000406 | | positive regulation of T cell migration | | Any process that activates or increases the frequency, rate or extent of T cell migration. |
| GO:2000570 | | positive regulation of T-helper 2 cell activation | | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell activation. |
| GO:0045630 | | positive regulation of T-helper 2 cell differentiation | | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation. |
| GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| GO:0046641 | | positive regulation of alpha-beta T cell proliferation | | Any process that activates or increases the frequency, rate or extent of alpha-beta T cell proliferation. |
| GO:0002699 | | positive regulation of immune effector process | | Any process that activates or increases the frequency, rate, or extent of an immune effector process. |
| GO:0002891 | | positive regulation of immunoglobulin mediated immune response | | Any process that activates or increases the frequency, rate, or extent of an immunoglobulin mediated immune response. |
| GO:0051024 | | positive regulation of immunoglobulin secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell. |
| GO:0050729 | | positive regulation of inflammatory response | | Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
| GO:0032729 | | positive regulation of interferon-gamma production | | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| GO:0032733 | | positive regulation of interleukin-10 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. |
| GO:0032735 | | positive regulation of interleukin-12 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
| GO:0032736 | | positive regulation of interleukin-13 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-13 production. |
| GO:0032743 | | positive regulation of interleukin-2 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
| GO:0032753 | | positive regulation of interleukin-4 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-4 production. |
| GO:2000572 | | positive regulation of interleukin-4-dependent isotype switching to IgE isotypes | | Any process that activates or increases the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes. |
| GO:0032755 | | positive regulation of interleukin-6 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| GO:2000568 | | positive regulation of memory T cell activation | | Any process that activates or increases the frequency, rate or extent of memory T cell activation. |
| GO:0043382 | | positive regulation of memory T cell differentiation | | Any process that activates or increases the frequency, rate or extent of memory T cell differentiation. |
| GO:0002830 | | positive regulation of type 2 immune response | | Any process that activates or increases the frequency, rate, or extent of a type 2 immune response. |
| GO:0002819 | | regulation of adaptive immune response | | Any process that modulates the frequency, rate, or extent of an adaptive immune response. |
| GO:0050727 | | regulation of inflammatory response | | Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. |
| GO:0035713 | | response to nitrogen dioxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus. |
| GO:0009615 | | response to virus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
cellular component |
| GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |